Jun. 2 at 10:32 AM
$NBRVF
Important Notice
The Depository Trust Company
B #: 24341-26
Date: May 29th, 2026
To: All Participants, Depository Facilities and Pledgee Banks
Category: Operations
From: Andrea Fenner
Attention: Managing Partners, Officers and Cashiers
Subject: Termination of DTC Services – Nabriva Therapeutics plc (CUSIP G63637139)
Please be advised that effective May 29th, 2026, Nabriva Therapeutics plc (CUSIP G63637139) no
longer meets DTC eligibility criteria.
The security has been chilled in preparation for an exit from DTC. Participants holding
shares in this security will be contacted directly by DTC to arrange the re-registration of these
shares on the transfer agent’s book